9.12.2019 |
EN |
Official Journal of the European Union |
C 413/60 |
Action brought on 14 October 2019 – Teva Pharmaceutical Industries v EUIPO (Moins de migraine pour vivre mieux)
(Case T-696/19)
(2019/C 413/72)
Language of the case: English
Parties
Applicant: Teva Pharmaceutical Industries Ltd (Jerusalem, Israel) (represented by: J. Bogatz and Y. Stone, lawyers)
Defendant: European Union Intellectual Property Office (EUIPO)
Details of the proceedings before EUIPO
Trade mark at issue: Application for European Union word mark Moins de migraine pour vivre mieux – Application for registration No 17 942 393
Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 12 August 2019 in Case R 778/2019-5
Form of order sought
The applicant claims that the Court should:
— |
annul the contested decision; |
— |
order EUIPO to pay the costs incurred by the applicant. |
Plea in law
Infringement of Article 7(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.